Basic Information | |
---|---|
Species | Fragaria vesca |
Cazyme ID | mrna11608.1-v1.0-hybrid |
Family | GT47 |
Protein Properties | Length: 498 Molecular Weight: 56622.1 Isoelectric Point: 9.6218 |
Chromosome | Chromosome/Scaffold: Start: 9188750 End: 9191784 |
Description | Exostosin family protein |
View CDS |
Signature Domain Download full data set without filtering | |||
---|---|---|---|
Family | Start | End | Evalue |
GT47 | 163 | 449 | 0 |
ERKFKVYVYSEGDLPITHDGPCKDIYSIEGRFIHEMETGAKAGRFRTKNPKEAHVYFMPFSVTWMVKYLYKPLSYDLRPLREYVSDYVRLVSEKYPFWNR TSGADHFMLACHDWAPHASAGNPFLYNTSIRVLCNANTSEGFRPQKDVSLPEIHLYGGYVSSKLISPPPTNTPRPYLAFFAGGLHGPIRPILLDYWKGRD ESLRVFEYLPKTLDYNSMMLESKFCLCPSGHEVASPRIVEAIYAECVPVIISEHYALPFSDVLRWEAFSIKVEVSEIKRLKEILEAV |
Full Sequence |
---|
Protein Sequence Length: 498 Download |
MESLRLQTTS VILWLCIASI LVVLVIYGSS DAPIGSSDSK SDLPVSIAIP MVQLRSKVIT 60 TTATSSVSDD HKIVLSSSNN NQSTTTPHLL PNQTPPREAA KRKRRSGRSK MEEGLARARS 120 SIRTAAAASG DPNRSSPPQN DVVSHGVVYR NPRAFHQSYL EMERKFKVYV YSEGDLPITH 180 DGPCKDIYSI EGRFIHEMET GAKAGRFRTK NPKEAHVYFM PFSVTWMVKY LYKPLSYDLR 240 PLREYVSDYV RLVSEKYPFW NRTSGADHFM LACHDWAPHA SAGNPFLYNT SIRVLCNANT 300 SEGFRPQKDV SLPEIHLYGG YVSSKLISPP PTNTPRPYLA FFAGGLHGPI RPILLDYWKG 360 RDESLRVFEY LPKTLDYNSM MLESKFCLCP SGHEVASPRI VEAIYAECVP VIISEHYALP 420 FSDVLRWEAF SIKVEVSEIK RLKEILEAVP EEKYRWLKKN LKVVRKHFEL NHPAKRFDVF 480 HMIMHSVWLR RINLRVA* |
Functional Domains Download unfiltered results here | ||||||||
---|---|---|---|---|---|---|---|---|
Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
pfam03016 | Exostosin | 4.0e-65 | 162 | 449 | 306 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. |
Gene Ontology | |
---|---|
GO Term | Description |
GO:0016020 | membrane |